Pfizer and BioNTech completed their submission to the FDA for emergency use authorization of their updated COVID-19 booster for children ages 5 through 11.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
